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From the Department of Urology, University of California School of Medicine, San Francisco, California 
A B S T R A C T 
We investigated the erectile response to intracavernous injection of increasing doses of acetylcho­
line (0.5 to 500 M g . ) in 10 monkeys. T o differentiate between nicotinic (ganglionic) and muscarinic 
(parasympathetic postganglionic) effects, acetylcholine was likewise administered after 1.6 mg. 
trimethaphan camsylate and 0.1 mg. atropine, alone or sequentially. Erections were induced by 
cavernous nerve stimulation before and after atropine. 
Acetylcholine induced a dose-dependent, triphasic erectile response: a first tumescence phase 
followed by contraction and a subsequent second phase of tumescence. Atropine reduced but did 
not abolish the erectile response to acetylcholine: attainment of maximal intracavernous pressure 
after neurostimulation was both delayed and reduced (mean 25 cm. H 2 0 ) . Only after combined 
nicotinic and muscarinic blockade was the erectile response to acetylcholine completely abolished. 
Histologic staining for acetylcholinesterase in five additional monkeys that had not received 
acetylcholine showed dense staining within the cavernous erectile tissue and around the cavernous 
arteries. 
Our data suggest that acetylcholine is a possible neurotransmitter for penile erection in monkeys. 
( J . Urol, 141: 1444-1448, 1989) 
Since the report of Eckhardt in 1863 that galvanic stimula­
t ion of pelvic parasympathetic nerves induces penile erection 
in the dog,1 many studies have confirmed these findings in 
different species.2"7 Based on the classic theory of autonomic 
neurotransmission, the muscarinic neurotransmitter was be­
lieved to be acetylcholine (ACh). 8 However, penile erection has 
been shown to be atropine-resistant, 9 , 1 0 and organ bath studies 
of the effect of ACh on cavernous smooth muscle have been 
inconclusive. I n vitro , all possible responses to ACh have been 
observed: no e f fect ; 1 1 1 2 inconsistent effects; 1 1 and both 
contraction 1 4 and re laxat ion 1 5 , 1 6 of the cavernous smooth mus­
cle. Our aim was to examine in vivo a possible role of ACh as 
a postganglionic parasympathetic neurotransmitter for penile 
erection. 
M A T E R I A L S A N D M E T H O D S 
Ten pigtail monkeys, weighing 4.3 to 10.5 kg., were used. 
After adequate anesthesia wi th ketamine (30 mg./kg. body-
weight i.m.), the monkeys were placed in the supine position. 
Under sterile conditions, one 21-gauge scalp-vein needle was 
placed in each distal right and left cavernous body. One needle 
was connected to a Statham transducer (model P23 BC) for 
intracavernous pressure recording (Grass Polygraph; model 7); 
the other served for intracavernous injection or perfusion. 
Penile tumescence was visually monitored by at least two 
investigators and recorded. The flow through the cavernous 
arteries was measured in four monkeys (No. 7-10) by duplex 
ultrasound. 1 7 Pulse and blood pressure were monitored closely 
wi th the aid of a Doppler probe (Parks Medical Electronics) on 
the radial artery and a pediatric blood pressure cuff (fig. 1). 
Intracavernous injection of ACh. A l l monkeys received doses 
of 0.5, 1 (5 x 10~9 mol.), 10, 100 and 500 Mg. ACh (Miocholine, 
Cooper Vision, Puerto Rico) by intracavernous injection. The 
effects of each dose were allowed to subside and a 10 to 15 
Accepted for publ icat ion D e c e m b e r 15, 1988. 
* R e q u e s t s for repr ints : D e p t . of Urology, U n i v e r s i t y of C a l i f o r n i a 
S c h o o l of M e d i c i n e , S a n F r a n c i s c o C A 94143. 
Supported by a grant from D e u t s c h e F o r s c h u n g s g e m e i n s c h a f t . 
minute waiting period intervened before the next injection. To 
verify reproducibility, all injections were given twice. 
Intracavernous injection of ACh after muscarinic blockade. 
The above injection protocol was followed after intracavernous 
injection of 0.1 mg. atropine (1.4 Χ 10" 7 mol.) (Elkins-Sim Inc., 
Cherry H i l l , N.Y.) . This dosage was chosen after 0.01 mg. 
intracavernously proved to be sufficient for complete musca­
rinic blockade in dogs (unpublished data). Although the size of 
the cavernous bodies in monkeys and dogs is comparable, a 
ten-fold increase (0.1 mg.) was selected to ensure complete local 
muscarinic blockade. 
Erections induced by neurostimulation before and after atro­
pine. I n monkeys 1-6, cuff electrodes were placed around the 
cavernous nerve as previously described. 1 8 After three erections 
had been induced by neurostimulation (20 Hz, six to eight V, 
stimulation time = one minute), 0.1 mg. atropine was injected 
intracavernously and neurostimulation was repeated five times 
w i t h an eight-minute interval between each stimulation. 
Intracavernous injection of ACh after nicotinic blockade. To 
investigate the effect of ACh after nicotinic blockade, the six 
monkeys w i t h implanted electrodes were given an intracaver­
nous injection of 1.6 mg. trimethaphan camsylate (Roche Lab­
oratories, Nutley, N.J.), the lowest dosage shown to block 
neurostimulation-induced erections in all monkeys. The drug's 
intrinsic activity resulted in penile tumescence wi th venous 
occlusion for 180 to 290 seconds (mean 235 seconds). However, 
during this period and for the next 180 to 200 seconds, the 
erectile response to neurostimulation was completely abolished. 
Acetylcholine (0.5 mg.) was injected intracavernously after 
trimethaphan camsylate's intrinsic activity had subsided (by 
direct vasodilation and smooth muscle relaxation) but during 
maintenance of nicotinic blockade. 
Injection of trimethaphan camsylate and ACh was repeated 
after 0.1 mg. atropine. 
The effect of ACh on the cavernous outflow. I n five monkeys, 
a flow probe was placed around the pudendal artery and the 
aorta was dissected for intermittent clamping w i t h a Satinsky 
clamp. W i t h the aorta clamped and the intracavernous pressure 
at baseline (mean 11 cm. H 2 0 ) , the penis was perfused w i t h 
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0.5 μς injection 
Pressure Recording 
F l G . 1. E r e c t i o n was induced in m o n k e y s by cavernous nerve s t i m ­
u l a t i o n or i n t r a c a v e r n o u s inject ion . A r t e r i a l response was measured by 
D u p l e x u l t r a s o u n d or by flow probe placed a r o u n d pudendal artery , or 
both . I n t r a c a v e r n o u s pressure response was recorded v i a needle i n ­
serted i n cavernous body. 
saline (37C) at increasing rates (3.8, 7.6, 15.3 and 26.6 m l . / 
min.) before and after 0.5 mg. ACh intracavernously. When the 
perfusion had continued for 60 seconds or the intracavernous 
pressure surpassed 200 cm. H 2 0 , i t was stopped. After intervals 
of 90, 60 and 60 seconds the penis was re-perfused. The clamp 
on the aorta was then released. 
Histologic staining for acetylcholinesterase. I n five monkeys 
in which no neurotransmitter studies had been performed (i.e. 
animals to be sacrificed by other departments at our inst i tu ­
t ion) , the aorta was clamped and the distal aorta was perfused 
w i t h two liters of saline to wash the red blood cells from the 
penile tissue. The penis was then immediately frozen and 
stained for acetylcholinesterase (AChE). 1 9 
R E S U L T S 
Intracavernous injection of ACh. Intracavernous injection of 
ACh induced a dose-dependent increase in penile tumescence, 
intracavernous pressure, and flow through the internal puden­
dal artery (fig. 2). The lowest dosage that induced penile 
tumescence was 0.5 μg. in three monkeys, one μg. in six, and 
10 μg. in one. The first observable change was an increase in 
arterial flow, followed by penile tumescence, and then, after 
some seconds, by an increase in intracavernous pressure. The 
duration of tumescence increased w i t h increasing dosages: from 
a mean of nine seconds (zero to 14 seconds) after 0.5 ^g. to a 
mean of 82 seconds (60 to 96) after 500 μg. ACh. 
A characteristic tri-phasic response was seen in seven mon­
keys with dosages up to 100 μg. and two monkeys up to 500 μg. 
Acetylcholine first induced penile tumescence and a rise in 
intracavernous pressure. This was followed by penile contrac­
t ion and a plateau in intracavernous pressure at a level above 
baseline (fig. 2). During penile contraction, the arterial flow 
wi th in the cavernous artery was markedly greater than in the 
flaccid state. This contraction was followed by another increase 
in tumescence and intracavernous pressure, both less dramatic 
than those in the first phase (table 1). 
Intracavernous 
Pressure 
(cm H20) 
1.0 μς 
10 μ ς 
100 μς 
Flow 
(ml/min) 
500 μς 
Intracavernous 
Pressure 
(cm H20) 
Flow 
(ml/min) 
mBH20) \f ( c  
F I G . 2. E r e c t i l e responses to i n t r a c a v e r n o u s inject ion of A C h at 
different doses. 
A multi-peaked, wave-shaped intracavernous pressure re­
sponse was seen after 100 μg. in three monkeys and after 500 
μg. in four (fig. 2). I n the majority, 0.5 μg. ACh caused the 
systemic blood pressure to fall below 40 mm. Hg for about 20 
to 40 seconds. 
Intracavernous injection of ACh after muscarinic blockade by 
atropine. Intracavernous injection of 0.1 mg. atropine was not 
followed by changes in heart rate or systemic blood pressure. 
I t induced an increase in the arterial flow of brief duration (five 
to 10 seconds) and slight tumescence lasting 10 to 25 seconds. 
The subsequent response to ACh remained dose-dependent: 0.5 
and one μg. did not result in tumescence, but only in penile 
contraction with a subsequent intracavernous pressure increase 
(table 1). Compared w i t h the effect induced by ACh alone, the 
response to ACh after atropine injection was markedly differ­
ent: the duration of tumescence and the increase in intracav­
ernous pressure and arterial flow were less; the contraction 
phase was more pronounced (high intracavernous pressure) 
and more prolonged; no second tumescence phase occurred. I n 
the monkeys wi th wave-shaped erectile responses to 100 and 
500 μg. ACh, the same doses after atropine induced a continu­
ous, sustained erectile response. 
Erection induced by neurostimulation before and after atro­
pine. I n all six monkeys w i t h electrodes around the cavernous 
nerve, electrical stimulation induced a reproducible ful l erec­
t ion. After 0.1 mg. atropine, the first neurostimulation produced 
the same full erection as before. I n the subsequent neurosti-
mulated erections, the phase u n t i l attainment of maximal i n ­
tracavernous pressure was prolonged by 10 to 34% (mean 28%; 
a mean delay of four seconds; ρ <0.001 [Student's t test]) and 
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T A B L E 1. Erectile response to acetylcholine before and after atropine 
A CU F i r s t T u m e s c e n c e C o n t r a c t i o n S e c o n d T u m e s c e n c e 
A L n 
t .. tr \ D u r a t i o n P r e s s u r e * D u r a t i o n P r e s s u r e D u r a t i o n P r e s s u r e 
( m i n . ) ( c m . H , 0 ) ( m i n . ) ( c m . H 2 0 ) ( m i n . ) ( c m . H , 0 ) 
0.5 15 3 5 t 90 60 60 32 
1 24 40 120 60 60 40 
10 32 65 120 60 70 40 
100 54 105 150 60 90 25 
500 84 120 180 75 90 25 
A f t e r 0.1 mg. a t r o p i n e 
0.5 - - 40 60 
1 - - 62 60 
10 14 42 165 90 
100 22 60 210 100 
500 30 75 260 100 
* I n t r a c a v e r n o u s p r e s s u r e . 
t N u m b e r s r e p r e s e n t m e a n v a l u e s for a l l m o n k e y s t h a t r e s p o n d e d (3 to 0.5 ^ g . , 6 to 1.0 ßg. 7 to 10 ^g . , a n d a l l 10 to 100 a n d 500 ßg). 
the ful l erection pressure was decreased by 12 to 20% (mean 
16% or 25 cm. H 2 0 ; ρ <0.05). The detumescence phase was 
unchanged. The immediate, strong increase in flow with in the 
internal pudendal artery at cavernous nerve stimulation was 
decreased by a mean of 29%. 
Intracavernous injection of ACh after nicotinic blockade by 
trimethaphan camsylate. Intracavernous injection of tr imetha­
phan camsylate was followed by a mean reduction in systemic 
blood pressure of 12 cm. H 2 0 for two to three minutes. After 
nicotinic blockade, intracavernous injection of 0.5 mg. ACh 
induced a similar erection to the one before trimethaphan 
camsylate, but attainment of maximal intracavernous pressure 
was delayed by a mean of nine seconds. 
The injection of 0.5 mg. ACh after 0.1 mg. atropine and 
nicotinic blockade induced slight penile tumescence in one of 
the six monkeys, but no tumescence or increase in intracav­
ernous pressure in five. 
The effect of ACh on the cavernous outflow. W i t h the aorta 
clamped, saline perfusion after ACh injection resulted in a 
perfusion-dependent plateau in intracavernous pressure w i t h ­
out penile tumescence. Immediately after injection of 0.5 mg. 
ACh, perfusion rates of 3.8 m l . / m i n . and higher induced full 
penile erection (intracavernous pressure > 200 cm. H 2 0 ) . Re-
perfusion after 90 seconds produced the same result. However, 
w i th the th i rd perfusion, flow rates up to 26.6 m l . / m i n . did not 
induce any tumescence, although, at the fourth perfusion, flow 
rates > 15.3 m l . / m i n . again induced ful l erection (fig. 3 ) . Thus, 
this perfusion study shows that intracavernous injection of 
ACh induced cavernous smooth muscle relaxation and subse­
quent cavernous outflow occlusion during the first two perfu­
sions, but no cavernous occlusion (or smooth muscle relaxation) 
during the th i rd . W i t h the fourth perfusion, cavernous occlu­
sion was again demonstrated, although i t was not as pro­
nounced as immediately after ACh injection (probably owing 
to a lesser degree of smooth muscle relaxation). Thus, the 
perfusion study confirmed the above-described findings of a 
triphasic erectile response to intracavernous ACh. 
Histologic findings. I n the histologic sections from the five 
monkeys, dense staining for acetylcholinesterase was seen 
around the cavernous artery, w i th in nerves near the cavernous 
artery, and wi th in the cavernous erectile tissues. No staining 
was found in the tunica albuginea (fig. 4). 
D I S C U S S I O N 
Intracavernous injection of ACh in the monkey induced a 
triphasic, dose-dependent erectile response: a first phase of 
penile tumescence and rigidity; a phase of penile contraction; 
and a second phase of penile tumescence, not as pronounced as 
the first. This triphasic reaction wi th contraction between two 
phases of tumescence may be explained by an immediate or 
reflexogenic release of noradrenaline from noradrenergic 
nerves. 2 0 Carbachol has been reported to induce a similar effect 
in vitro: cavernous smooth muscle relaxation followed by con-
11 min I 
F I G . 3. W i t h aorta c l a m p e d a n d 500 μg. A C h injected i n t r a c a v ­
ernously , sa l ine perfusion induced venous occ lus ion at minutes 0 a n d 
1 (first tumescence phase ) . A t minute 3, no venous occlusion could be 
induced by perfusion rates below 26.6 m l . / m i n . (contract ion p h a s e ) . 
T h e n , at minutes 5 a n d 7, venous occlusion w a s produced by flow rates 
of 15.3 m l . / m i n . a n d greater. 
tract ion. 1 5 After the effect of noradrenaline on its receptors has 
subsided, the second phase of tumescence could be explained 
by the ongoing effect of ACh on the cavernous smooth muscles 
in combination wi th the ongoing increase in arterial flow. The 
init ia l small dip in the intracavernous pressure at the beginning 
of this second phase of tumescence (fig. 2) can easily be ex­
plained by the elongation of the penis at this time. 
Intracavernous ACh provoked an immediate, strong increase 
in arterial flow, which subsided somewhat but remained at 
moderately increased levels during the three phases. These 
pressure and flow effects were not due solely to a muscarinic 
cholinergic effect because they could not be completely blocked 
by atropine. Only after the additional intracavernous injection 
of a nicotinic blocker did ACh induce no erectile response. 
These observations correspond to the findings of Adaikan and 
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F l G . 4. D e n s e acety lchol inesterase -posi t ive areas (dark spots) were found A, a r o u n d cavernous arteries a n d B, w i t h i n cavernous erectile t issue. 
( M a g n i f i c a t i o n X 200 a n d X 400 for A a n d B, respectively . ) 
coworkers, 1 3 who demonstrated muscarinic and nicotinic chol-
inoreceptors in human cavernous tissue. This overlapping of 
muscarinic and nicotinic effects after the intracavernous injec-
t ion of ACh, together w i t h an increasing effect on the systemic 
blood pressure wi th doses of 0.1 and 0.5 mg., can explain the 
two (or more) wave-shaped erectile responses to high doses of 
ACh in seven monkeys. 
Atropine modulated but did not abolish the erectile response 
to neurostimulation. The reduction of the immediate increase 
in arterial flow led to a prolongation of the tumescence phase. 
This and the decreased intracavernous pressure were supported 
as signs of incomplete cavernous relaxation by the staining of 
AChE around the cavernous artery and wi th in the cavernous 
smooth muscles on histologic examination. 
Our findings of the erectile response to intracavernous injec-
t ion of ACh are in agreement wi th other in vivo studies: partial 
or fu l l erections have been described after ACh in the rabbit" 1 
I and dog; 2 2 atropine has been shown to reduce significantly the 
erectile response to pelvic and hypogastric nerve stimulation in 
the dog,4 cat 2 3 and rabbit ; 2 1 AChE-containing nerve fibers have 
been found in the cavernous tissue and around the cavernous 
I artery in man and different animal species. 1 1 , 1 2 ' 2 4" 2 6 
A t variance, Henderson et al. observed no erectile response 
! after intraaortic injection of ACh. 3 This lack of effect may be 
due to the immediate inactivation of ACh by the AChE in the 
blood, to the pronounced lowering of the systemic blood pres-
sure after high doses of ACh, or to the fact that the pressure in 
I the glans instead of in the cavernous bodies was recorded. The 
abil ity of atropine to antagonize penile erection in man could 
I not be proven in two studies . 9 1 0 However, intracavernous pres-
sure was not monitored by invasive means and a 15 or 20% 
j lowering of the maximal pressure could have been easily missed. 
Results of in vitro studies of the effect of ACh on the 
cavernous smooth muscle have been contradictory, showing a 
range of results: no e f fect ; 1 1 1 2 inconsistent effects; 1 3 contrac-
t i o n ; 1 4 and r e l a x a t i o n . 1 5 1 6 These contradictory findings may 
have several causes. To prove a relaxing effect, the cavernous 
smooth muscle must first be contracted by electrical or phar-
macologic means. I n the studies in which the smooth muscles 
were contracted by norepinephrine before ACh was given, a 
relaxing effect could be shown. Secondly, the human cavernous 
smooth muscle, like the monkey's, w i l l probably react to intra -
cavernous injection of ACh in a triphasic manner, but the dog 
responds w i t h a single phase of tumescence and rigidity (un-
published data). Third ly , the action of ACh may be dependent 
on an intact cavernous endothelium (Goldstein, I . : personal 
communication). I n the studies in which no effect was observed, 
the cavernous endothelium may have been damaged during 
preparation of the tissue. 
Our study showed that intracavernous injection of ACh in 
the monkey induces a dose-dependent erectile response by 
increasing the arterial flow, relaxing the cavernous smooth 
muscles, and occluding the cavernous outflow. These in vivo 
results, together wi th the histologic findings of AChE-positive 
fibers around the cavernous artery and wi th in the cavernous 
erectile tissue, suggest that ACh may be a neurotransmitter for 
penile erection. The fact that atropine could only diminish, but 
not abolish, the erectile response to neurostimulation suggests 
the presence of additional postganglionic parasympathetic neu-
rotransmitters for erection. There is strong evidence that vas-
oactive intestinal polypeptide (VIP) may be one of these. 2 7 - 3 0 
We have observed that the combination of atropine and ant i -
V I P likewise only reduces the erectile response to neurostim-
ulation (unpublished data), and therefore further studies are 
needed to uncover additional neurotransmitters involved in 
penile erection. 
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